OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preclinical development of plant‐based oral immune modulatory therapy for haemophilia B
Aparajitha Srinivasan, Roland W. Herzog, Imran Khan, et al.
Plant Biotechnology Journal (2021) Vol. 19, Iss. 10, pp. 1952-1966
Open Access | Times Cited: 24

Showing 24 citing articles:

Debulking SARS-CoV-2 in saliva using angiotensin converting enzyme 2 in chewing gum to decrease oral virus transmission and infection
Henry Daniell, Smruti K. Nair, Nardana Esmaeili, et al.
Molecular Therapy (2021) Vol. 30, Iss. 5, pp. 1966-1978
Open Access | Times Cited: 59

Delivery of biologics: Topical administration
Rachel J. Kulchar, Rahul Singh, Suwan Ding, et al.
Biomaterials (2023) Vol. 302, pp. 122312-122312
Open Access | Times Cited: 21

Affordable oral proinsulin bioencapsulated in plant cells regulates blood sugar levels similar to natural insulin
Henry Daniell, Rahul Singh, Venkata Mangu, et al.
Biomaterials (2023) Vol. 298, pp. 122142-122142
Open Access | Times Cited: 16

Development of an efficient marker‐free soybean transformation method using the novel bacterium Ochrobactrum haywardense H1
Hyeon‐Je Cho, York Moy, Nathan A. Rudnick, et al.
Plant Biotechnology Journal (2022) Vol. 20, Iss. 5, pp. 977-990
Open Access | Times Cited: 26

Plants as Sources of Natural and Recombinant Antimalaria Agents
Peyman Habibi, Yao Shi, Maria Fátima Grossi‐de‐Sá, et al.
Molecular Biotechnology (2022) Vol. 64, Iss. 11, pp. 1177-1197
Open Access | Times Cited: 25

Plant cell-based drug delivery enhances affordability of biologics
Henry Daniell, Rachel J. Kulchar, Roland W. Herzog, et al.
Nature Biotechnology (2023) Vol. 41, Iss. 9, pp. 1186-1187
Closed Access | Times Cited: 11

Synthetic and Biogenic Materials for Oral Delivery of Biologics: From Bench to Bedside
Suwan Ding, Elena Alexander, Huiyi Liang, et al.
Chemical Reviews (2025)
Closed Access

Immune complications and their management in inherited and acquired bleeding disorders
Valder R. Arruda, David Lillicrap, Roland W. Herzog
Blood (2022) Vol. 140, Iss. 10, pp. 1075-1085
Open Access | Times Cited: 13

Debulking Influenza and Herpes Simplex virus strains by a wide-spectrum anti-viral protein formulated in clinical grade chewing gum.
Henry Daniell, Yuwei Guo, Rahul Singh, et al.
Molecular Therapy (2024) Vol. 33, Iss. 1, pp. 184-200
Open Access | Times Cited: 2

Abatement of microfibre pollution and detoxification of textile dye – Indigo by engineered plant enzymes
Geetanjali Wakade, Shina Lin, Prasenjit Saha, et al.
Plant Biotechnology Journal (2022) Vol. 21, Iss. 2, pp. 302-316
Open Access | Times Cited: 11

Potential role for oral tolerance in gene therapy
John S. Butterfield, Xin Li, Sreevani Arisa, et al.
Cellular Immunology (2023) Vol. 391-392, pp. 104742-104742
Open Access | Times Cited: 5

Evaluation of Biologics ACE2/Ang(1–7) Encapsulated in Plant Cells for FDA Approval: Safety and Toxicology Studies
Henry Daniell, Geetanjali Wakade, Smruti K. Nair, et al.
Pharmaceutics (2024) Vol. 17, Iss. 1, pp. 12-12
Open Access | Times Cited: 1

Oral tolerance to prevent anti-drug antibody formation in protein replacement therapies
Jyoti Rana, Maite Munoz, Moanaro Biswas
Cellular Immunology (2022) Vol. 382, pp. 104641-104641
Closed Access | Times Cited: 7

Distinct functions and transcriptional signatures in orally induced regulatory T cell populations
Moanaro Biswas, Kaman So, Thaís B. Bertolini, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3

In silico analysis and in planta production of recombinant ccl21/IL1β protein and characterization of its in vitro anti-tumor and immunogenic activity
Hassan Marashi, Maria Beihaghi, Masoud Chaboksavar, et al.
PLoS ONE (2022) Vol. 17, Iss. 8, pp. e0261101-e0261101
Open Access | Times Cited: 3

Factor IX stimulants in preclinical and early phase trials for hemophilia B treatment
Massimo Franchini, Daniele Focosi
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 9, pp. 939-944
Closed Access

Factor IX administration in the skin primes inhibitor formation and sensitizes hemophilia B mice to systemic factor IX administration
Alexandra Sherman, Thaís B. Bertolini, Sreevani Arisa, et al.
Research and Practice in Thrombosis and Haemostasis (2023) Vol. 7, Iss. 8, pp. 102248-102248
Open Access | Times Cited: 1

Page 1

Scroll to top